Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
NCT00604812
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine Disorders
Interventions
DRUG:
rizatriptan benzoate (5 mg)
DRUG:
rizatriptan benzoate (10 mg)
DRUG:
Rizatriptan 5 mg Placebo
DRUG:
Rizatriptan 10 mg Placebo
Sponsor
Organon and Co